| 1, 2, 3-Triazole-[2, 5-Bis-O-(tert-butyldimethylsilyl)-. beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'', 2''-oxathiole 2'', 2''-dioxide)(TSAO) Analogs: Synthesis and Anti … R Alvarez, S Velazquez, A San-Felix, S Aquaro, ED Clercq, CF Perno, ... Journal of medicinal chemistry 37 (24), 4185-4194, 1994 | 1031 | 1994 |
| Phase I studies of 2', 3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT) R Yarchoan, RV Thomas, JP Allain, N Mcatee, R Dubinsky, H Mitsuya, ... The Lancet 331 (8577), 76-81, 1988 | 636 | 1988 |
| In vivo activity against HIV and favorable toxicity profile of 2′, 3′-dideoxyinosine R Yarchoan, H Mitsuya, RV Thomas, JM Pluda, NR Hartman, CF Perno, ... Science 245 (4916), 412-415, 1989 | 568 | 1989 |
| Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine R Yarchoan, P Brouwers, AR Spitzer, J Grafman, B Safai, CF Perno, ... The Lancet 329 (8525), 132-135, 1987 | 443 | 1987 |
| Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative M Baba, H Tanaka, E De Clercq, R Pauwels, J Balzarini, D Schols, ... Biochemical and biophysical research communications 165 (3), 1375-1381, 1989 | 394 | 1989 |
| Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral … CF Perno, R Yarchoan, DA Cooney, NR Hartman, DS Webb, Z Hao, ... The Journal of experimental medicine 169 (3), 933-951, 1989 | 326 | 1989 |
| European guidelines on the clinical management of HIV-1 tropism testing LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ... The Lancet infectious diseases 11 (5), 394-407, 2011 | 314 | 2011 |
| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ... The Lancet infectious diseases 16 (5), 565-575, 2016 | 287 | 2016 |
| Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2 … CF Perno, R Yarchoan, DA Cooney, NR Hartman, S Gartner, M Popovic, ... The Journal of experimental medicine 168 (3), 1111-1125, 1988 | 280 | 1988 |
| Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir S Aquaro, R Caliò, J Balzarini, MC Bellocchi, E Garaci, CF Perno Antiviral research 55 (2), 209-225, 2002 | 265 | 2002 |
| 2', 5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'', 2''-oxathiole-2'', 2'-dioxide) pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human … J Balzarini, MJ Perez-Perez, A San-Felix, D Schols, CF Perno, ... Proceedings of the National Academy of Sciences 89 (10), 4392-4396, 1992 | 248 | 1992 |
| Factors determining the activity of 2', 3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro. Z Hao, DA Cooney, NR Hartman, CF Perno, A Fridland, AL DeVico, ... Molecular Pharmacology 34 (4), 431-435, 1988 | 237 | 1988 |
| Therapeutic drug monitoring in HIV infection: current status and future directions D Back, G Gatti, C Fletcher, R Garaffo, R Haubrich, R Hoetelmans, ... Aids 16, S5-S37, 2002 | 230 | 2002 |
| HIV‐1 genetic variability and clinical implications MM Santoro, CF Perno International Scholarly Research Notices 2013 (1), 481314, 2013 | 229 | 2013 |
| Cytomegalovirus coinfection is associated with an increased risk of severe non–AIDS-defining events in a large cohort of HIV-infected patients M Lichtner, P Cicconi, S Vita, A Cozzi-Lepri, M Galli, S Lo Caputo, ... The Journal of infectious diseases 211 (2), 178-186, 2015 | 220 | 2015 |
| Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018 MC Sorbo, V Cento, VC Di Maio, AYM Howe, F Garcia, CF Perno, ... Drug Resistance Updates 37, 17-39, 2018 | 217 | 2018 |
| Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants V Mollace, HSLM Nottet, P Clayette, MC Turco, C Muscoli, D Salvemini, ... Trends in neurosciences 24 (7), 411-416, 2001 | 212 | 2001 |
| Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection J Balzarini, S Hatse, K Vermeire, K Princen, S Aquaro, CF Perno, ... Antimicrobial agents and chemotherapy 48 (10), 3858-3870, 2004 | 205 | 2004 |
| Updated European recommendations for the clinical use of HIV drug resistance testing AM Vandamme, A Sönnerborg, M Ait-Khaled, J Albert, B Asjo, L Bacheler, ... Antiviral therapy 9 (6), 829-848, 2004 | 197 | 2004 |
| Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives. J Balzarini, A Karlsson, S Aquaro, CF Perno, D Cahard, L Naesens, ... Proceedings of the National Academy of Sciences 93 (14), 7295-7299, 1996 | 192 | 1996 |
